Skip to main content
. 2019 Jan 3;33(1):281–287. doi: 10.21873/invivo.11473

Figure 1. Overall survival according to response to different first-line therapies. Plots show survival of patients treated with (A) first-line chemotherapy (log-rank test, p<0.028) and (B) first-line endocrine therapy (log-rank test, p=0.001). Solid lines: patients with good response to first-line therapy; dotted lines: patients with poor response to first-line therapy.

Figure 1